Allovir Inc
NASDAQ:ALVR
Allovir Inc
NASDAQ:ALVR
Price:
11.47
USD
16.92%
Market Closed
Market Cap:
$35.1m
Income Statement
Earnings Waterfall
Allovir Inc
Allovir Inc
Income Statement
Allovir Inc
Allovir Inc
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(46)
|
(71)
|
(92)
|
(118)
|
(139)
|
(170)
|
(182)
|
(189)
|
(187)
|
(171)
|
(171)
|
(174)
|
(178)
|
(181)
|
(161)
|
(121)
|
(80)
|
(55)
|
|
| Selling, General & Administrative |
(13)
|
(22)
|
(29)
|
(38)
|
(44)
|
(49)
|
(53)
|
(54)
|
(55)
|
(52)
|
(51)
|
(50)
|
(50)
|
(48)
|
(46)
|
(41)
|
(34)
|
(43)
|
|
| Research & Development |
(33)
|
(50)
|
(63)
|
(80)
|
(96)
|
(121)
|
(129)
|
(135)
|
(132)
|
(119)
|
(121)
|
(124)
|
(128)
|
(133)
|
(115)
|
(80)
|
(45)
|
(12)
|
|
| Operating Income |
(46)
N/A
|
(71)
-55%
|
(92)
-29%
|
(118)
-28%
|
(139)
-18%
|
(170)
-22%
|
(182)
-7%
|
(189)
-4%
|
(187)
+1%
|
(171)
+8%
|
(171)
0%
|
(174)
-2%
|
(178)
-2%
|
(181)
-2%
|
(161)
+11%
|
(121)
+25%
|
(80)
+34%
|
(55)
+31%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
6
|
6
|
5
|
5
|
5
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(19)
|
(28)
|
(29)
|
(29)
|
(10)
|
|
| Total Other Income |
1
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
0
|
2
|
2
|
3
|
4
|
4
|
3
|
2
|
1
|
|
| Pre-Tax Income |
(45)
N/A
|
(70)
-57%
|
(91)
-31%
|
(117)
-28%
|
(139)
-19%
|
(171)
-23%
|
(184)
-8%
|
(191)
-4%
|
(187)
+2%
|
(169)
+10%
|
(166)
+2%
|
(167)
0%
|
(169)
-1%
|
(191)
-13%
|
(180)
+6%
|
(140)
+22%
|
(100)
+29%
|
(59)
+41%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(45)
|
(70)
|
(91)
|
(117)
|
(139)
|
(172)
|
(185)
|
(192)
|
(189)
|
(169)
|
(166)
|
(167)
|
(169)
|
(190)
|
(180)
|
(140)
|
(100)
|
(59)
|
|
| Net Income (Common) |
(45)
N/A
|
(70)
-57%
|
(91)
-31%
|
(117)
-28%
|
(139)
-19%
|
(172)
-24%
|
(185)
-8%
|
(192)
-4%
|
(189)
+2%
|
(169)
+11%
|
(166)
+2%
|
(167)
0%
|
(169)
-1%
|
(190)
-13%
|
(180)
+6%
|
(140)
+22%
|
(100)
+29%
|
(59)
+41%
|
|
| EPS (Diluted) |
-0.72
N/A
|
-1.13
-57%
|
-1.46
-29%
|
-1.89
-29%
|
-2.23
-18%
|
-2.74
-23%
|
-2.88
-5%
|
-2.97
-3%
|
-2.21
+26%
|
-2.2
+0%
|
-1.77
+20%
|
-1.76
+1%
|
-1.48
+16%
|
-1.83
-24%
|
-1.56
+15%
|
-1.23
+21%
|
-0.88
+28%
|
-11.69
-1 228%
|
|
Switch to:
Switch to:
See Also
Discover More
